GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sinocare Inc (SZSE:300298) » Definitions » EV-to-EBITDA

Sinocare (SZSE:300298) EV-to-EBITDA : 28.63 (As of Jun. 03, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Sinocare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sinocare's enterprise value is ¥12,140 Mil. Sinocare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ¥424 Mil. Therefore, Sinocare's EV-to-EBITDA for today is 28.63.

The historical rank and industry rank for Sinocare's EV-to-EBITDA or its related term are showing as below:

SZSE:300298' s EV-to-EBITDA Range Over the Past 10 Years
Min: 14.47   Med: 38.53   Max: 103.75
Current: 28.63

During the past 13 years, the highest EV-to-EBITDA of Sinocare was 103.75. The lowest was 14.47. And the median was 38.53.

SZSE:300298's EV-to-EBITDA is ranked worse than
75.35% of 495 companies
in the Medical Devices & Instruments industry
Industry Median: 15.61 vs SZSE:300298: 28.63

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-03), Sinocare's stock price is ¥21.00. Sinocare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.574. Therefore, Sinocare's PE Ratio (TTM) for today is 36.59.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Sinocare EV-to-EBITDA Historical Data

The historical data trend for Sinocare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocare EV-to-EBITDA Chart

Sinocare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.46 61.39 26.68 34.29 22.56

Sinocare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.94 39.18 61.47 22.56 31.96

Competitive Comparison of Sinocare's EV-to-EBITDA

For the Medical Devices subindustry, Sinocare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocare's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sinocare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sinocare's EV-to-EBITDA falls into.


;
;

Sinocare EV-to-EBITDA Calculation

Sinocare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12140.071/423.96
=28.63

Sinocare's current Enterprise Value is ¥12,140 Mil.
Sinocare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥424 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocare  (SZSE:300298) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Sinocare's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.00/0.574
=36.59

Sinocare's share price for today is ¥21.00.
Sinocare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.574.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Sinocare EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sinocare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocare Business Description

Traded in Other Exchanges
N/A
Address
No.265 Guyuan Road, Hi-tech Zone, Hunan Province, Changsha, CHN, 410205
Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.
Executives
Li Xin Yi Director
Li Shao Bo Directors, executives
Che Hong Jing Director
Wang Shi Min Executives
Huang An Guo Directors, executives
Directors, executives
Pan Shu Guang Securities Affairs Representative
Zhou Qing Hua Supervisors
Ning Gui Chun Supervisors
Wang Rui Securities Affairs Representative
Chen Ji Dong Supervisors
Che Hong Li Directors, executives
Zhang Fan Director

Sinocare Headlines

No Headlines